State Street’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
Other funds holding OTLK
PA
HF
GWM
State Street's OTLK Position: Q2 2026 in Review
State Street increased its Outlook Therapeutics (OTLK) stake by 231% in Q2 2026, buying an estimated $234K and bringing the position to 539,802 shares worth $858K. The position accounts for ﹤0.01% of the portfolio, ranked #3487.
State Street first reported a position in OTLK in Q2 2021 and has held it in 21 quarters since. The position peaked at $4.79M in Q2 2023. 69 funds tracked by Wall St. Rank hold OTLK as of Q2 2026.
- State Street held 539,802 shares of Outlook Therapeutics worth $858K as of Q2 2026.
- State Street bought 376,700 Outlook Therapeutics shares in Q2 2026, an estimated $234K.
- Outlook Therapeutics made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3487 holding.
- State Street first reported a position in Outlook Therapeutics in Q2 2021 and has held it in 21 quarters since.
- State Street's Outlook Therapeutics position peaked at $4.79M in Q2 2023.
- 69 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2026.
Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.